255 related articles for article (PubMed ID: 12418950)
1. The risk of recurrent venous thromboembolism in heterozygous carriers of factor V Leiden and a first spontaneous venous thromboembolism.
Eichinger S; Weltermann A; Mannhalter C; Minar E; Bialonczyk C; Hirschl M; Schönauer V; Lechner K; Kyrle PA
Arch Intern Med; 2002 Nov; 162(20):2357-60. PubMed ID: 12418950
[TBL] [Abstract][Full Text] [Related]
2. Is recurrent venous thromboembolism more frequent in homozygous patients for the factor V Leiden mutation than in heterozygous patients?
Procare Group
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):523-9. PubMed ID: 12960604
[TBL] [Abstract][Full Text] [Related]
3. Influence of the 4600A/G and 4678G/C polymorphisms in the endothelial protein C receptor (EPCR) gene on the risk of venous thromboembolism in carriers of factor V Leiden.
Medina P; Navarro S; Estellés A; Vayá A; Bertina RM; España F
Thromb Haemost; 2005 Aug; 94(2):389-94. PubMed ID: 16113830
[TBL] [Abstract][Full Text] [Related]
4. Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).
Pabinger I; Ay C; Dunkler D; Thaler J; Reitter EM; Marosi C; Zielinski C; Mannhalter C
J Thromb Haemost; 2015 Jan; 13(1):17-22. PubMed ID: 25381723
[TBL] [Abstract][Full Text] [Related]
5. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
[TBL] [Abstract][Full Text] [Related]
6. The risk of recurrent venous thromboembolism among heterozygous carriers of factor V Leiden or prothrombin G20210A mutation. A systematic review of prospective studies.
Marchiori A; Mosena L; Prins MH; Prandoni P
Haematologica; 2007 Aug; 92(8):1107-14. PubMed ID: 17650440
[TBL] [Abstract][Full Text] [Related]
7. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
[TBL] [Abstract][Full Text] [Related]
8. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
[TBL] [Abstract][Full Text] [Related]
9. Incidence of venous thromboembolism in asymptomatic family members who are carriers of factor V Leiden: a prospective cohort study.
Simioni P; Tormene D; Prandoni P; Zerbinati P; Gavasso S; Cefalo P; Girolami A
Blood; 2002 Mar; 99(6):1938-42. PubMed ID: 11877263
[TBL] [Abstract][Full Text] [Related]
10. The incidence of recurrent venous thromboembolism in carriers of factor V Leiden is related to concomitant thrombophilic disorders.
Meinardi JR; Middeldorp S; de Kam PJ; Koopman MM; van Pampus EC; Hamulyák K; Prins MH; Büller HR; van der Meer J
Br J Haematol; 2002 Mar; 116(3):625-31. PubMed ID: 11849222
[TBL] [Abstract][Full Text] [Related]
11. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
[TBL] [Abstract][Full Text] [Related]
12. The incidence of venous thromboembolism among Factor V Leiden carriers: a community-based cohort study.
Heit JA; Sobell JL; Li H; Sommer SS
J Thromb Haemost; 2005 Feb; 3(2):305-11. PubMed ID: 15670037
[TBL] [Abstract][Full Text] [Related]
13. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
Rintelen C; Pabinger I; Knöbl P; Lechner K; Mannhalter C
Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
[TBL] [Abstract][Full Text] [Related]
15. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of factor V Leiden and Factor II A20210 mutations and recurrent venous thromboembolism.
Margaglione M; D'Andrea G; Colaizzo D; Cappucci G; del Popolo A; Brancaccio V; Ciampa A; Grandone E; Di Minno G
Thromb Haemost; 1999 Dec; 82(6):1583-7. PubMed ID: 10613638
[TBL] [Abstract][Full Text] [Related]
17. Testing for factor V Leiden in patients with pulmonary or venous thromboembolism: a cost-effectiveness analysis.
Eckman MH; Singh SK; Erban JK; Kao G
Med Decis Making; 2002; 22(2):108-24. PubMed ID: 11958494
[TBL] [Abstract][Full Text] [Related]
18. The risk of first venous thromboembolism during pregnancy and puerperium in double heterozygotes for factor V Leiden and prothrombin G20210A.
Martinelli I; Battaglioli T; De Stefano V; Tormene D; Valdrè L; Grandone E; Tosetto A; Mannucci PM;
J Thromb Haemost; 2008 Mar; 6(3):494-8. PubMed ID: 18182035
[TBL] [Abstract][Full Text] [Related]
19. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
20. Type and location of venous thromboembolism in patients with factor V Leiden or prothrombin G20210A and in those with no thrombophilia.
Martinelli I; Battaglioli T; Razzari C; Mannucci PM
J Thromb Haemost; 2007 Jan; 5(1):98-101. PubMed ID: 17067362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
